Minerva Medical Treatment Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.14%
(FY 2023)
- Profit -25.56%
(FY 2023)
- Ebitda -21.60%
(FY 2023)
- Net Worth 74.70%
(FY 2023)
- Total Assets 28.07%
(FY 2023)
About Minerva Medical Treatment
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vidush Singhania, Meghna Singhania, Anita Aggarwal, and One other member serve as directors at the Company.
- CIN/LLPIN
U74900DL2011PTC214315
- Company No.
214315
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Minerva Medical Treatment?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidush Singhania  | Director | 01-Dec-2019 | Current |
| Prem Aggarwal | Director | 17-Feb-2011 | Current |
| Meghna Singhania | Director | 17-Feb-2011 | Current |
| Anita Aggarwal | Director | 28-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Minerva Medical Treatment.
Minerva Medical Treatment Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.14% increase. The company also saw a substantial fall in profitability, with a 25.56% decrease in profit. The company's net worth Soared by an impressive increase of 74.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Minerva Medical Treatment?
In 2023, Minerva Medical Treatment had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Everything Medical Private Limited
Active
6 years 28 days Meghna Singhania and Prem Aggarwal are mutual person
Didua Analytics Private Limited
Active 5 years 6 months Vidush Singhania and Meghna Singhania are mutual person
Probity Technology For Integrity In Sports Private Limited
Active 3 years 2 days Vidush Singhania is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Minerva Medical Treatment?
Unlock and access historical data on people associated with Minerva Medical Treatment, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Minerva Medical Treatment, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Minerva Medical Treatment's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
